The Nottingham study of neurotic disorder: predictors of 12 year costs

Authors:

Abstract
Objective: To examine the relationship between clinical, demographic and socio‐economic characteristics and the long‐term costs of a cohort of neurotic patients.Method: Analysis of the costs of a cohort of 210 people entered in the Nottingham study of neurotic disorders, a randomized controlled evaluation of five treatments for neurotic disorders. Service use data were collected at 5 and 12 years after study entry. Multiple regression analyses were conducted.Results: The total cost per patient over the 12‐year follow‐up period was calculated to be $11 940 (SD $15 520) (£7450, SD £9690). Higher costs were significantly associated with the presence of general neurotic syndrome, an initial diagnosis of dysthymia and a recurrent episode of illness.Conclusion: The total costs of care for a range of neurotic disorders are broadly comparable with other estimates of costs reported in the literature for similar populations. Those responsible for higher costs in the longer‐term have comorbid anxiety, depressive and personality disorders.

This publication has 34 references indexed in Scilit: